Fundraising Fox
/Companies
Sign in

VitriVax

Boulder, US · Delaware corporation · 5 known investors

Find your way into VitriVax

Sign up to see every warm intro you have to VitriVax

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the VitriVax team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Develops a thermostable, single-injection vaccine formulation platform.

Biotech

Founders & leadership

TRTheodore Randolph
Theodore RandolphFounder
RCRomulo Colindres
Romulo ColindresExecutiveRomulo Colindres is a pharmaceutical executive with experience in medical affairs, epidemiology, clinical development, market access, regulatory affairs, and pharmacovigilance. He leads VitriVax as executive officer and director.

Board

GRGlenn Rockman
Glenn RockmanBoard directorCo-Founder and Partner at Adjuvant Capital
RL
Rene LorenzBoard director
LB
Louise BradyBoard director

Investors · 5

Adjuvant Capitallisted by Adjuvant CapitalNew York · $10M – $25M

How we know: Adjuvant Capital's portfolio page · a partner's Signal profile · funding news · press coverage · Not right? Tell us

Buff Gold Ventureslisted by Buff Gold VenturesBoulder

How we know: Buff Gold Ventures's portfolio page · Not right? Tell us

Colorado BioScience Associationlisted by Colorado BioScience Association

How we know: Colorado BioScience Association's portfolio page · Not right? Tell us

CU Healthcare Innovation Fundlisted by CU Healthcare Innovation FundAurora
RA Capitallisted by RA CapitalBoston

How we know: RA Capital's portfolio page · funding news · press coverage · Not right? Tell us

Funding

SEC filings, press & company announcements

$29.4M disclosed across 1 of 2 rounds · 2021–2025

▶$29.4MraisedNov 2025 · 83 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Glenn RockmanDirector
  • Rene LorenzDirector
  • Louise BradyDirector
  • Theodore RandolphDirector
  • Romulo ColindresExecutive Officer, Director, Promoter
Offering amount
$37.1M
Amount sold
$29.4M
First sale
Jun 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does VitriVax do?
Develops a thermostable, single-injection vaccine formulation platform.
Who founded VitriVax?
VitriVax was founded by Theodore Randolph.
Who are VitriVax's investors?
VitriVax's investors include Adjuvant Capital, Buff Gold Ventures, Colorado BioScience Association, CU Healthcare Innovation Fund, RA Capital.
How much funding has VitriVax raised?
VitriVax has disclosed $29.4M raised across 1 of its 2 known rounds.
Where is VitriVax headquartered?
VitriVax is headquartered in Boulder, US.